Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor ...

William Blair has recently reduced Maravai Lifesciences Holdings Inc (MRVI) stock to Mkt Perform rating, as announced on November 8, 2024, according to Finviz. Earlier, on August 28, 2024, Wells Fargo ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) shares gapped down before the market opened on Friday after Royal Bank of Canada lowered their price target on the stock from $17.00 ...

Tejas Savant, an analyst from Morgan Stanley, maintained the Hold rating on Maravai Lifesciences Holdings (MRVI – Research Report). The associated price target was lowered to $7.00. Tejas Savant has ...